Recent developments in nanoscale robots and targeted therapies are bringing us closer to revolutionary clinical applications in oncology.
Microscopic precision tools designed to target cancer cells while sparing healthy tissue.
Researchers have developed nanorobots capable of selectively targeting and destroying cancer cells in mice. These nanorobots remain inactive while circulating in the body and activate only upon encountering the tumor microenvironment, thereby sparing healthy cells. This approach has shown promise in preclinical studies and represents a significant step toward targeted cancer therapies.
Read research paperScientists from Caltech have engineered microrobots thinner than a human hair, designed to deliver drugs directly to cancer cells. In mouse models, these microrobots successfully reduced bladder tumor sizes, demonstrating their potential for precise drug delivery and minimally invasive treatments.
View Caltech researchWhile human trials involving nanorobots are still forthcoming, the field is rapidly advancing. Nanobiotix, a French biotechnology company, has developed NBTXR3, a radioenhancer using nanotechnology to make cancer cells more receptive to radiotherapy. NBTXR3 has completed Phase II/III clinical trials for soft tissue sarcoma and received European market approval under the trade name Hensify®. The company is also conducting additional trials for other cancer types, including head and neck cancers.
Learn about NBTXR3 clinical trialsStay informed about the latest developments in nanomedicine for cancer treatment
Scientists develop microscopic machines that can target tumor cells with unprecedented precision, potentially revolutionizing cancer treatment protocols.
Read full articleCaltech researchers demonstrate microrobots that can navigate through complex environments to deliver targeted therapeutics directly to tumors.
Read full articleMagnetically controlled nanorobots show promise in treating previously inaccessible tumors, offering hope for patients with aggressive cancers.
Read full articleSubscribe to our newsletter for exclusive insights and breaking news on nanotechnology developments in cancer treatment.